Chromatin immunoprecipitation (ChIP) using anti-TRF2 antibody followed by qPCR in fibrosarcoma HT1080 and MDA-MB-231 breast carcinoma cells showed TRF2 occupancy at the p21 promoter (Fig. 1A). This evidence concerns the gene CDKN1A and breast carcinoma.